A Fork in the Road – Weaning Support, Moving Toward LVAD/Transplant, or Considering Palliative Options

Who Recovers and Who Does Not Recover in Cardiogenic Shock?

Anju Bhardwaj, MD

Which Cardiogenic Shock Patient Is Eligible for Durable LVAD or Cardiac Transplantation?

Claudius Mahr

When Is It Time to Throw in the Towel – Can We Define Futility in Cardiogenic Shock?

David M Dudzinski, MD

Goals of Palliative Care in the Management of the Cardiogenic Shock Patient

Ajar Kochar, M.D., FSCAI

Breakfast Program: Best of Shock Cases

A Series of Unfortunate Events: A Case of Recurrent LAD Thrombosis Complicated by Cardiogenic Shock Managed With Percutaneous Left Axillary VA-ECMO Cannulation

Sandeep Mahesh Patel, M.D., FSCAI

Management of Massive Pulmonary Embolism after Intraparenchymal Hemorrhage with Mechanical Thrombectomy

Sarah Grebennikov

Saving the unsalvageable: Emergent transcatheter aortic valve-in-valve and transcatheter mitral valve-in-valve replacement for cardiogenic shock from dual bioprosthetic valve stenosis and insufficiency

Monika Karki

Recognizing Left Ventricular Distension: A Case of Low-Flow VA-ECMO as a Bridge-to-Transplant in a Patient with Significant Aortic Regurgitation

Andrew H. Nguyen, DO

Breakfast Program: High-Risk and Complex PCI—What's in a Name?

Welcoming Remarks

Alexander G. Truesdell, M.D., FSCAI

CHIP “Mindset”: Not Just the Anatomy, What About the Patient?

Dr. Aditya Bharadwaj, M.B.B.S., FSCAI

Discussion

Poonam Velagapudi, MD MS, FSCAI

Multidisciplinary Heart Team Approach to Coronary Revascularization

Alejandro Lemor, M.D., FSCAI

Discussion

Alexander G. Truesdell, M.D., FSCAI

MCS Use for High-Risk PCI: Optimal Decision-Making

Rebecca Chester, MD

Discussion

Poonam Velagapudi, MD MS, FSCAI

Intravascular Imaging: See What You Treat

Hiram G Bezerra, M.D., Ph.D.

Discussion

Alexander G. Truesdell, M.D., FSCAI

Calcium Modification: Strategies and Technologies

Ajar Kochar, M.D., FSCAI

Discussion

Poonam Velagapudi, MD MS, FSCAI

Complications: Plan, Prevent, Manage

Amir Kaki, M.D., FSCAI

Discussion

Alexander G. Truesdell, M.D., FSCAI

How to Train for the Future? Should Everyone Be Doing CHIP?

Alexander G. Truesdell, M.D., FSCAI

Discussion

Poonam Velagapudi, MD MS, FSCAI

Building a Cardiogenic Shock Team Workshop: Group Case Review (COURSE FULL)

Case 1

Iyad N Isseh, MD

Case 2

Allison G. Dupont, M.D., FSCAI, Jason J Grady

Case 3: Cone Health

Building a Cardiogenic Shock Team Workshop: How and Why We Started our Shock Program (COURSE FULL)

The Need for DCSI

Babar B Basir, DO, FSCAI

Translating Best Practice to My Community Hospital

Alexander G. Truesdell, M.D., FSCAI

Translating Best Practice to my Community Hospital

Allison G. Dupont, M.D., FSCAI

Transplanting Best Practice to My Community Hospital

Raymond Yau, MD, FSCAI

Outcomes & Data Collection (Teams Share Their Data)

Babar B Basir, DO, FSCAI

Building a Cardiogenic Shock Team Workshop: Nuts and Bolts of Implementing a Shock Team (COURSE FULL)

Shock Activation Process

Carolyn M. Rosner, MSN, RN, FNP-BC

ICU Models

Rachna Kataria

I Need to Transfer the Patient

Rola Khedraki, MD

How we Review our Shock Cases

Alexander G. Truesdell, M.D., FSCAI

When Do We Start Weaning and Recovery

Jennifer Cowger, MD

Building a Cardiogenic Shock Team Workshop: The Finances of a Shock Team (COURSE FULL)

The Financial Benefits of a Shock Program

Rick Clark

How to Develop a Business Model for a Shock Program

Andrea Daniels, RN, MSN

How to ask for Support: Insider Knowledge to get the Support Your Program Needs

Ruth Fisher

Building a Cardiogenic Shock Team Workshop: Welcome and Introductions (COURSE FULL)

Welcoming Remarks

Babar B Basir, DO, FSCAI

Case Presentations and Hors d'oeuvres

The Utilization of ECMO and Mechanical Thrombectomy in Treatment of a Massive Pulmonary Embolism After Failed Fibrinolysis

Sahil Prasada, MD

Native Heart Recovery in Peripartum Cardiomyopathy Complicated by Cardiogenic Shock: A Multidisciplinary Approach

Brian Ssembajjwe, MD

Refractory Electrical Storm Managed with VA-ECMO as a Bridge to Durable LVAD

Gurleen Kaur

Rapid Shock Transfer Process Success Using a Heart Team Approach in Non-Academic Hub Center

Tulio Diaz, M.D.

Contemporary Management of PE Patients in Shock: Moving Beyond Lytics

Welcoming Remarks

Babar B Basir, DO, FSCAI

Why Should Shock Experts Care About PE? Clinical Evidence: A Contemporary Review

Vikas Aggarwal, M.B.B.S., FSCAI

AC/Lytics/CBL/Thrombectomy – When to Do What?

Amir Kaki, M.D., FSCAI

ECMO and Other MCS Devices in PE

Poonam Velagapudi, MD MS, FSCAI

Who Are You Enrolling in the Trials?

Catalin Toma, M.D.

CTEPH and Chronic Disease

Mitul P. Patel, M.D., FSCAI

Discussion

Amir Kaki, M.D., FSCAI

ECMO in the Community

Starting an ECMO Program in the Community

Raymond Yau, MD, FSCAI

ECMO Without Surgical Backup

Sandeep Mahesh Patel, M.D., FSCAI

Interfacility Transport: Getting From Spoke to Hub

Omar Hernandez

ECMO, Part 2

LV Venting Strategies

Navin K. Kapur, M.D., FSCAI

How to Wean VA ECMO

Mirnela Byku, MD, PhD, MBA

Strategies for Durable/Central ECMO Support

Amy Hackmann, MD

eCPR: When and How?

Jason Bartos, M.D., Ph.D.

ECMO Transport

Jason J Grady

Future Directions of Shock

Future Pipeline of MCS Devices

Navin K. Kapur, M.D., FSCAI

Novel (and Not so Novel) Noninvasive Devices for Hemodynamic Monitoring of Cardiogenic Shock Patients

Jennifer Cowger, MD

Breaking Down Barriers to Enrollment in Cardiogenic Shock Trials

Saraschandra Vallabhajosyula, MD MSc, FSCAI

Could AI Be a Game Changer in the Care of Cardiogenic Shock Patients?

Song Li, MD

Lunch Program: Navigating the Right Heart: From Diagnosis to Innovative Interventions

Demystifying RHF: What we Know

Navin K. Kapur, M.D., FSCAI

Emerging Insights: RHF in CGS

Babar B Basir, DO, FSCAI

Balancing Risks: Mixed Shock and RV Dysfunction

Sarah Gorgis, MD

Balancing Risks: Managing Right Heart Failure in High-Risk PCI

Sara Negrotto, M.D.

Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock

Welcoming Remarks

Jennifer A Rymer, MD, MBA, MHS

Case Presentation, Part 1

Anezi Uzendu

The Pharmacodynamics of Antiplatelet and Antithrombotic Therapies in Cardiogenic Shock: How to Mitigate Ischemia and Bleeding

Timothy D. Henry, M.D., MSCAI

Discussion

Jennifer A Rymer, MD, MBA, MHS

The Use of Cangrelor in ACS and Cardiogenic Shock: Lessons Learned from Trial and Registry Data

Jennifer A Rymer, MD, MBA, MHS

Discussion

Jennifer A Rymer, MD, MBA, MHS

Optimal Antiplatelet and Antithrombotic Strategies in High-Risk ACS and Special Patient Populations: Not Your Textbook Patients

Greg W Serrao, MD, FSCAI

Case Presentation, Part 2

Anezi Uzendu

Discussion

Jennifer A Rymer, MD, MBA, MHS

Shock Teams in the Community: Part 1

Tips for Process Improvements: Order Sets and Buy In

Dr. Aditya Bharadwaj, M.B.B.S., FSCAI

How to Create a Financial Stable Program

Andrea Daniels, RN, MSN

How to Create a Hub and Spoke Model

Rola Khedraki, MD

Effective Nuances of Shock Transfers and Transportation

Jason J Grady

Shock Teams in the Community: Part 2

How we Changed our Shock Outcomes in Rural America

Bassel Alkhalil, MD

How to ask for What you Need

Ruth Fisher

Why we Need a Shock Coordinator

Stephanie Koepke, MSN, ACNS-BC

Why we Need Advanced Heart Failure Cardiologist in the Community

Rachna Kataria

Strategies to Disrupt SCAI Stage B Progression

Critical Care Cardiology Perspective

Jason Neil Katz, MD

Heart Failure and Transplantation Perspective

Rachna Kataria

Interventional Cardiology Perspective

Allison G. Dupont, M.D., FSCAI

Critical Care Transport/EMS Coordination Perspective

Jason J Grady

The Cardiogenic Shock Team

Who's on the Team?

Shashank Sinha, MD, MSc

How Do You Activate?

Alexander G. Truesdell, M.D., FSCAI

Who's the Quarterback?

Carolyn M. Rosner, MSN, RN, FNP-BC

Where Do Patients Go? (i.e., Transfers to ER, CICU, CTU, or CCL?)

Marwan Jumean, M.D., FSCAI

Choosing Devices and Therapies (Temporary to Durable)

Jaime Hernandez-Montfort, MD MPH MSc

The Forgotten Cardiogenic Shock Causes

Aortic/Mitral Valvular Cardiogenic Shock

Sahil Khera, M.D., FSCAI

Congenital Heart Disease

Holly Bauser-Heaton, M.D., Ph.D., FSCAI

Post-MI VSD Shock

Sarah Gorgis, MD

Post-Cardiotomy

Brian Lima, MD

Pregnancy and Shock

Anna Bortnick, M.D., Ph.D., FSCAI

The Shock ICU

After the Device Goes In, What’s Next? Keys to Successfully Transitioning the Patient to the Cardiac ICU

Elliott Miller, M.D.

Debate: Coordination of Cardiogenic Shock Care: The Critical Care Cardiologist Should Direct Management for the Cardiogenic Shock Patient

Robert O. Roswell, MD

Debate: Coordination of Cardiogenic Shock Care: The Advanced HF and Transplant Cardiologist Should Direct Management for the Cardiogenic Shock Patient

Lindsey Aurora, M.D.

My Patient Is Not Getting Better – Considerations for Escalating Support in Cardiogenic Shock

Brett Sheridan, MD

Specific Goals and Strategies for Mechanical Ventilation in Cardiogenic Shock

Jason Neil Katz, MD

Renal Replacement Therapy for the Cardiogenic Shock Patient – Should We Start Early?

David M Dudzinski, MD

Yearly Updates in Cardiogenic Shock

Approaches to Complete Hemodynamic Profiles in Cardiogenic Shock

Sophia Airhart, MD

SCAI Stage and Phenotypes

David A. Baran, M.D., FSCAI

Year in Shock: Updates in Trial Data

Sandeep Nathan, M.D., FSCAI

Disparities in Care in Cardiogenic Shock

Saraschandra Vallabhajosyula, MD MSc, FSCAI

2023 SCAI SHOCK

SCAI SHOCK